SCHEMBL14224729

SCHEMBL14224729

C=C(C)c1cc(C=C(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
CYP3A4 P08684 4/20 0.46
CYP1A2 P05177 4/20 0.46
CYP2C9 P11712 4/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 3/20 0.46
TSHR P16473 3/20 0.46
BLM P54132 3/20 0.46
KMT2A Q03164 3/20 0.46
HSD17B10 Q99714 3/20 0.46
ALDH1A1 P00352 3/20 0.46
CYP2C19 P33261 3/20 0.46
RGS12 O14924 2/20 0.46
GMNN O75496 2/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 2/20 0.46
NFKB1 P19838 2/20 0.46
THPO P40225 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7175613 0.84 SMN1; SMN2 (0.61) SMN1; SMN2CYP3A4CYP1A2CYP2C9MEN1
SCHEMBL8260206 0.81 MEN1 (0.53) SMN1; SMN2CYP3A4CYP1A2CYP2C9MEN1
SCHEMBL10458268 0.77 CA2 (0.61) SMN1; SMN2CYP1A2CYP2C9MAPTALDH1A1
SCHEMBL805444 0.77 CA2 (0.45) SMN1; SMN2CYP3A4CYP1A2CYP2C9MEN1
SCHEMBL805430 0.75 NR5A2 (0.48) SMN1; SMN2CYP3A4CYP1A2CYP2C9MEN1
SCHEMBL12240426 0.75 CA2 (0.59) SMN1; SMN2CYP1A2CYP2C9MAPTALDH1A1
SCHEMBL2811722 0.75 CA2 (0.65) SMN1; SMN2CYP1A2CYP2C9MAPTALDH1A1
SCHEMBL12651295 0.75 SMN1; SMN2 (0.63) SMN1; SMN2CYP1A2CYP2C9MEN1MAPT
SCHEMBL13178842 0.74 CA2 (0.42) SMN1; SMN2CYP1A2CYP2C9MEN1MAPT
SCHEMBL13299510 0.74 CA2 (0.42) SMN1; SMN2CYP3A4CYP1A2CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096894-A1 Anti-Bacterial Compounds ASTON UNIVERSITY (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096894-A1 Anti-Bacterial Compounds MRPL21, PGLS, FOSB SMN1; SMN2 4485/4885CYP3A4 3723/4885CYP1A2 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.